|
Event Registration for Clinicians in Practice | Consensus or Controversy? Immune Checkpoint Inhibition in the Management of Metastatic Lung Cancer — November 8, 2018, Washington, DCThis program is intended for medical oncologists, hematology-oncology fellows and other allied healthcare professionals involved in the treatment of lung cancer. You are now registering as a practicing physician, fellow or other healthcare provider involved in the treatment of cancer. If you are not a clinician in practice, please register as a nonclinician. |